Matthew Charles McMurdo

Director, Titan Pharmaceuticals.

Companies

Indaptus Therapeutics, Inc.Board member Feb 26, 2026 to now¹
FiEE, Inc.Board member Jan 4, 2024 to Oct 1, 2024²
OpGen (United States)Board member Apr 3, 2024 to Apr 12, 2024³
Titan PharmaceuticalsBoard member Aug 25, 2022 to Oct 26, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

FiEE, Inc. FIEE184,364 shares⁵$649.0K at $3.52Sep 26, 2024
OpGen (United States) CFOR100,000 shares⁶$350.0K at $3.50Apr 11, 2024
Indaptus Therapeutics, Inc. INDP25,000 shares⁷$69.5K at $2.78Feb 26, 2026
Titan Pharmaceuticals TTNP66,250 shares⁸Oct 25, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 26, 2024Granted 159,364 shares of FiEE, Inc.⁵
Apr 11, 2024Granted 100,000 shares of OpGen (United States)⁶
Jan 22, 2024Granted 25,000 shares of FiEE, Inc.⁹
Oct 25, 2023Granted 16,250 shares of Titan Pharmaceuticals⁸
Jul 26, 2023Granted 50,000 shares of Titan Pharmaceuticals¹⁰
Jul 26, 2023Granted 50,000 shares of Titan Pharmaceuticals¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIndaptus Therapeutics, Inc., Board member
2
SEC EDGARFiEE, Inc., Board member
3
SEC EDGAROpGen (United States), Board member
4
SEC EDGARTitan Pharmaceuticals, Board member
5
SEC EDGARFiEE, Inc. shares after the filing of Sep 26, 2024
6
SEC EDGAROpGen (United States) shares after the filing of Apr 11, 2024
7
SEC EDGARIndaptus Therapeutics, Inc. shares after the filing of Feb 26, 2026
8
SEC EDGARTitan Pharmaceuticals shares after the filing of Oct 25, 2023
9
SEC EDGARForm 4 filed Jan 24, 2024
10
SEC EDGARForm 4 filed Jul 31, 2023
11
SEC EDGARForm 4 filed Jul 28, 2023